Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.

International journal of cancer - 1 Sept 2015

Andrew Angeline S, Marsit Carmen J, Schned Alan R, Seigne John D, Kelsey Karl T, Moore Jason H, Perreard Laurent, Karagas Margaret R, Sempere Lorenzo F

Abstract excerpt

Bladder cancer is the fourth most common cancer among men in the United States and more than half of patients experience recurrences within 5 years after initial diagnosis. Additional clinically informative and actionable biomarkers of the recurrent bladder cancer phenotypes are needed to improve screening and molecular therapeutic approaches for recurrence prevention. MicroRNA-34a (miR-34a) is a short noncoding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cell Line

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to MicroRNAs

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Urinary Bladder Neoplasms

Share to Urothelium

Source

Open in PubMed Open full text

Identifiers

PMID: 25556547
DOI: 10.1002/ijc.29413
PMCID: PMC4485975

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.PMID 25556547Read ↗

Molecular Determinants of Tumor Recurrence in The Urinary BladderSemantic proximity Read ↗

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read ↗

The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to TreatmentSemantic proximity Read ↗

Identification of a nine‐gene panel as a prognostic indicator for recurrence with muscle‐invasive bladder cancerSemantic proximity Read ↗

A methylation assay for the detection of non‐muscle‐invasive bladder cancer (NMIBC) recurrences in voided urineSemantic proximity Read ↗

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter StudySemantic proximity Read ↗

Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional studySemantic proximity Read ↗

Genome‐wide identification of urinary cell‐free micro RNA s for non‐invasive detection of bladder cancerSemantic proximity Read ↗

Uromonitor <sup>®</sup> as a novel sensitive and specific urine-based test for recurrence surveillance of patients with non-muscle invasive bladder cancerSemantic proximity Read ↗

The expression of cancer stem cells and its effects on the propensity for recurrence and metastasis in bladder cancer: a systematic reviewSemantic proximity Read ↗

Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancerSemantic proximity Read ↗

MicroRNAs as Noninvasive Biomarkers in Bladder Cancer Detection: A Diagnostic Meta-Analysis Based on qRT-PCR DataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.